L-Arginine

With peptides

L-arginine pairs naturally with the GH-secretagogue peptide cluster via the "double-stimulus" mechanism — arginine inhibits somatostatin (the GH brake) while GHRH-class peptides activate the GHRH receptor (the GH accelerator). The combination is the classical approach used in clinical GH stimulation testing. Sermorelin (GHRH 1-29) and CJC-1295 (long-acting GHRH analog) are commonly stacked with pre-bed arginine for endogenous GH support protocols. Ipamorelin (GHRP/ghrelin-mimetic) is often added — the GHRP + GHRH + arginine triple stack produces the most robust GH response of these combinations. Note: this is a goal-specific stack for users targeting GH/IGF-1 support, not general health.

With supplements

1. L-citrulline — for NO/vascular targeting, citrulline is the more efficient tool due to first-pass arginase escape. Most contemporary NO-research protocols use citrulline alone rather than arginine. If using both, citrulline does the NO-elevation work; arginine adds the GH-secretagogue effect.
2. L-ornithine — partner amino acid in the urea cycle; ornithine + arginine pre-bed is a traditional GH-support combination with modest evidence for synergistic GH release.
3. Glutamine — surgical immunonutrition partner. Standard clinical immunonutrition formulas (Impact, Oxepa) combine arginine, glutamine, omega-3s, and antioxidant micronutrients.
4. Vitamin C and zinc — wound healing co-factors. Arginine drives collagen substrate availability; vitamin C is the collagen-hydroxylation cofactor; zinc supports tissue repair more broadly.
5. Pycnogenol (pine bark extract) — Stanislavov 2008 trial documented additive ED improvements with Pycnogenol + L-arginine combination.
6. Lysine — competes with arginine for transport in herpes-susceptible users. If you have HSV history and want arginine for other reasons, balancing with lysine supplementation is a partial mitigation.

With lifestyle

1. Take pre-bed on empty stomach for GH support. Somatostatin tone is high at rest, making this the window where arginine's mechanism produces the largest GH effect.
2. Avoid pre-workout dosing for performance. Arginine blunts rather than enhances the natural exercise GH spike. For pre-workout pump/NO, use L-citrulline malate.
3. Split divided doses. Single doses above 5–6 g often cause GI distress due to absorption ceiling overflow. 2–3 × 2–3 g across the day is better tolerated than 1 × 6–9 g.
4. Adequate dietary protein. 0.8–1.2 g/kg dietary protein provides ~5–6 g endogenous arginine from food. Supplementation is additive to this baseline, not corrective for deficient diet.
5. Pre-op washout. Stop arginine 1–2 weeks before scheduled surgery — modest antihypertensive effect can complicate intraoperative management.
6. Post-MI hold. Do not start arginine supplementation in the 30 days post-myocardial infarction without cardiology supervision (VINTAGE-MI adverse signal).

Common (mostly transient)

1. GI distress — nausea, diarrhea, bloating at higher doses (5+ g single dose). Splitting doses resolves most cases.
2. Mild blood pressure reduction — generally favorable but relevant for users on antihypertensives.
3. No documented serious adverse events at standard supplemental doses in healthy adults (outside the post-MI population).

Less common (watch-list)

1. Herpes simplex outbreak risk. HSV viral replication requires arginine; lysine competes with arginine for cellular transport. Arginine supplementation may precipitate or worsen outbreaks in users with HSV-1/HSV-2 history. Lysine co-supplementation is a partial mitigation if arginine is needed for other reasons.
2. Post-MI mortality signal (VINTAGE-MI). Do not initiate arginine supplementation within 30 days of myocardial infarction without cardiology supervision.
3. Electrolyte shifts at very high doses. Doses above 20 g/day in clinical contexts have been associated with mild electrolyte imbalances.
4. Rare allergic reactions — uncommon but documented.
5. Rare reports of pancreatitis at very high doses (case reports, not RCT-level evidence).

Drug and supplement interactions

1. Antihypertensive medications. Additive BP-lowering effect. Monitor during titration.
2. PDE5 inhibitors (sildenafil, tadalafil). Additive vasodilation. Generally well-tolerated but coordinate with prescriber for users on combination protocols.
3. Anticoagulants and antiplatelets. Modest theoretical bleeding risk via NO-mediated platelet inhibition. Generally tolerated; monitor for unusual bruising.
4. Nitrate medications (nitroglycerin, isosorbide). Additive vasodilation — coordinate with cardiologist.
5. Insulin and oral hypoglycemics — modest improvement in insulin sensitivity may require diabetes medication adjustment in long-term users.
6. Pregnancy — generally safe under obstetric supervision; arginine has been studied in pregnancy hypertension and pre-eclampsia.

Should I take L-arginine or L-citrulline for nitric oxide?

For raising plasma arginine and nitric oxide, take L-citrulline — not L-arginine. The reason is counterintuitive but well-documented: oral L-arginine undergoes extensive first-pass metabolism in the intestine (by arginase) and liver before reaching systemic circulation, so a large proportion of an oral dose never makes it to the bloodstream. L-citrulline is absorbed efficiently, escapes hepatic arginase, and is converted to arginine in the kidneys — producing higher and longer-lasting plasma arginine levels than equimolar L-arginine. Schwedhelm 2008 and Moinard 2008 are the foundational pharmacokinetic studies. Contemporary nitric oxide research has largely shifted to L-citrulline for this reason. L-arginine remains relevant for its growth hormone secretagogue effect, wound healing, and specific clinical contexts — but for pre-workout NO/pump or chronic vascular support, citrulline is the better tool.

Does L-arginine actually raise growth hormone?

Yes, but the effect is context-dependent. Intravenous arginine reliably produces a large GH spike — this is the basis of the arginine GH stimulation test used clinically to diagnose adult GH deficiency. Oral arginine produces a more modest GH response: doses of 5–9 g at rest or before sleep increase resting GH levels (Kanaley 2008 review). The catch: arginine taken around exercise tends to blunt the exercise-induced GH spike rather than enhance it — the natural exercise GH response is already near-maximal, and arginine can interfere rather than add. Practical implication: if you're using arginine for GH support, take it pre-bed on an empty stomach, not pre-workout.

How much L-arginine should I take?

Depends on the goal. For GH support at rest: 3–9 g pre-bed on empty stomach. For cardiovascular/blood pressure support: 3–6 g daily in divided doses. For male fertility support (sperm parameters): 5–10 g daily for 1–3 months. For wound healing under medical supervision: 6–20 g daily. For erectile dysfunction: typically 5 g daily, though L-citrulline at 1.5–3 g is now preferred. Higher doses produce more GI distress with diminishing returns due to the absorption ceiling. Split divided doses (3 × 2 g rather than 1 × 6 g) reduces GI side effects.

Will L-arginine give me a better pump in the gym?

Probably not — and this is one of the more durable supplement-marketing/research divergences. Pre-workout supplements have featured L-arginine for decades because the NO-precursor mechanism is biologically real, but the bioavailability ceiling means that a typical 1–3 g pre-workout dose produces only modest plasma arginine increases. RCTs of acute oral L-arginine on resistance exercise performance and pump have largely been null or weakly positive. L-citrulline at 6–8 g (or citrulline malate at 8 g) produces measurable improvements in resistance exercise volume and perceived pump. If your pre-workout includes L-arginine for pump effects, swap to L-citrulline.

Can L-arginine help with erectile dysfunction?

Modestly, and again L-citrulline is now preferred. The NO/cGMP pathway underlying erectile function is well-characterized — PDE5 inhibitors (sildenafil, tadalafil) work by preserving cGMP downstream. L-arginine works upstream by supplying NOS substrate. Older trials at 5 g/day showed modest ED improvements. The Cormio 2011 L-citrulline trial (1.5 g/day) showed comparable or better results at much lower doses due to citrulline's pharmacokinetic advantage. For users targeting ED through the NO pathway, citrulline is the more efficient tool. Arginine remains relevant in some combination products (e.g., pine bark extract/Pycnogenol + arginine — Stanislavov 2008).

Is L-arginine safe? Any major contraindications?

Generally safe at typical supplemental doses. Two important contraindications: (1) Recent myocardial infarction — the VINTAGE-MI trial found increased post-MI mortality with L-arginine supplementation; do not take L-arginine after recent heart attack without cardiology supervision. (2) Active herpes simplex outbreaks — arginine is required for HSV viral replication, and lysine competes with arginine for transport into cells; arginine supplementation may worsen herpes outbreaks in susceptible users. Other watch-list items: modest blood pressure reduction (additive with antihypertensives), GI distress at high doses, potential allergic reactions, and rare reports of pancreatitis at very high doses. Coordinate with prescribing clinician if on blood pressure or anticoagulant medication.

Can I stack L-arginine with GH peptides like sermorelin?

Yes — and the stack has a long history in GH-support protocols. GHRH-analog peptides like sermorelin and CJC-1295 stimulate GH release by acting on the GHRH receptor; arginine works through a complementary mechanism by inhibiting somatostatin (the GH brake). The combination is the classical "double-stimulus" approach used in clinical GH stimulation testing. For at-home protocols targeting endogenous GH support, taking 3–9 g L-arginine pre-bed on empty stomach complements GHRH-class peptide injection timing. Note: this is for users specifically targeting GH/IGF-1 support; not relevant for general health users.

Why does the body convert citrulline to arginine but oral arginine doesn't work as well?

This is the elegant counterintuitive pharmacology at the heart of the NO supplementation field. Oral L-arginine encounters intestinal arginase (the enzyme that breaks arginine down to ornithine and urea) immediately upon absorption, and any surviving arginine then encounters hepatic arginase on first pass. By the time arginine reaches systemic circulation, much of an oral dose is gone. L-citrulline is not a substrate for arginase — it passes through intestine and liver intact, reaches the kidneys, and is converted to arginine by argininosuccinate synthetase/lyase enzymes that work outside the first-pass arginase exposure. Counterintuitively, supplementing the precursor (citrulline) raises plasma arginine more than supplementing arginine itself. This is the central reason contemporary NO research uses citrulline.